Mesenchymal stem cells and immune disorders: from basic science to clinical transition / 医学前沿
Frontiers of Medicine
; (4): 138-151, 2019.
Article
em En
| WPRIM
| ID: wpr-771295
Biblioteca responsável:
WPRO
ABSTRACT
As a promising candidate seed cell type in regenerative medicine, mesenchymal stem cells (MSCs) have attracted considerable attention. The unique capacity of MSCs to exert a regulatory effect on immunity in an autologous/allergenic manner makes them an attractive therapeutic cell type for immune disorders. In this review, we discussed the current knowledge of and advances in MSCs, including its basic biological properties, i.e., multilineage differentiation, secretome, and immunomodulation. Specifically, on the basis of our previous work, we proposed three new concepts of MSCs, i.e., "subtotipotent stem cell" hypothesis, MSC system, and "Yin and Yang" balance of MSC regulation, which may bring new insights into our understanding of MSCs. Furthermore, we analyzed data from the Clinical Trials database ( http//clinicaltrials.gov ) on registered clinical trials using MSCs to treat a variety of immune diseases, such as graft-versus-host disease, systemic lupus erythematosus, and multiple sclerosis. In addition, we highlighted MSC clinical trials in China and discussed the challenges and future directions in the field of MSC clinical application.
Palavras-chave
Texto completo:
1
Base de dados:
WPRIM
Assunto principal:
Fisiologia
/
Ensaios Clínicos Controlados Aleatórios como Assunto
/
Diferenciação Celular
/
Transplante de Células-Tronco Mesenquimais
/
Medicina Regenerativa
/
Alergia e Imunologia
/
Células-Tronco Mesenquimais
/
Doenças do Sistema Imunitário
Tipo de estudo:
Clinical_trials
Limite:
Humans
Idioma:
En
Ano de publicação:
2019
Tipo de documento:
Article